DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Genetic Disorder

Miller-Dieker Syndrome

HIGH SEVERITY

Rare genetic disorder caused by deletion of chromosome 17p13.3 including LIS1 gene. Characterized by lissencephaly (smooth brain), severe developmental delay, seizures, and characteristic facial features. Life-limiting condition.

Global Affected

5.0K

Countries

15

Symptoms

Severe developmental delay
Seizures
Hypotonia
Feeding difficulties
Failure to thrive
Characteristic facial features
Lissencephaly

Treatment Options

Antiepileptic medications
G-tube feeding
Physical therapy
Respiratory support
Palliative care
Seizure rescue medications

Risk Factors

1Chromosomal deletion 17p13.3
2Advanced maternal age
3Parental inversion carriers

Diagnostic Methods

  • 1Brain MRI
  • 2Genetic testing (FISH, microarray)
  • 3Clinical evaluation
  • 4EEG
  • 5Developmental assessment

Prognosis

Severe neurodevelopmental impairment. Most do not achieve developmental milestones beyond 3-5 months. Seizures often refractory to treatment. Life expectancy typically 2-10 years. Death usually due to respiratory complications or infections. Some survive into teens with intensive support. No regression but no significant developmental gains.

Prevention

  • Genetic counseling
  • Prenatal diagnosis
  • Preimplantation genetic diagnosis
  • Carrier screening

Research Status

Supportive care only. Seizure management with multiple antiepileptics. G-tube feeding for nutrition. Physical therapy. No curative treatment available. Palliative care focus.

Sources

  • https://www.ncbi.nlm.nih.gov/books/NBK1116
  • https://rarediseases.org
  • https://www.mayoclinic.org

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.